Pfizer Plans Chesterfield R&D Campus

Published 12-7-2016

Pfizer will begin construction in mid-2017 on a $200 million research and development campus in Chesterfield, Mo. Supporting the creation of advanced vaccines, biotherapeutics, and pharmaceuticals, the project could include a 460,000-sf facility standing up to five stories high. The campus will be built by Clayco and its development subsidiary CRG, with Pfizer leasing the structures upon completion. Occupancy is expected in 2020.